1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Siegal, G.
Davis, B.
Kristensen, S.M.
Sankar, A.
Linacre, J.
Stein, R.C.
Panayotou, G.
Waterfield, M.D.
Driscoll, P.C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
276
461
478
10.1006/jmbi.1997.1562
9512716
Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
1998
10.2210/pdb1bfj/pdb
pdb_00001bfj
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12746.247
P85 ALPHA
C TERMINAL SH2 DOMAIN
1
man
polymer
PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA SUBUNIT, PI3-KINASE P85-ALPHA SUBUNIT
no
no
MEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLK
ELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR
MEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLK
ELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
Escherichia
Escherichia coli
sample
BL21
9913
BRAIN
Bos taurus
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PET-23D
BL21
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-02-25
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1997-11-18
REL
NO NOE VIOLATION > 0.3A, NO DIHEDRAL VIOLATION > 3.0
100
1
VARIOUS
50 mM
7.5
1
atm
290
K
30 CONFORMERS WERE DETERMINED BY RESTRAINED MOLECULAR DYNAMICS/SIMULATED ANNEALING METHOD USING THE PROGRAM X-PLOR 3.84. THE STRUCTURES ARE BASED ON 1908 INTERPROTON DISTANCE RESTRAINTS DERIVED FROM NOE MEASUREMENTS; 88 HYDROGEN-BONDING DISTANCE RESTRAINTS FOR 44 HYDROGEN-BONDS IDENTIFIED ON THE BASIS OF THE NOE AND AMIDE PROTON EXCHANGE DATA; 25 TORSION ANGLE RESTRAINTS DERIVED FROM COUPLING CONSTANTS AND NOE DATA. THE RMS DISTRIBUTION ABOUT THE MEAN COORDINATE POSITIONS IS 0.57 ANGSTROMS FOR ALL BACKBONE ATOMS AND 1.12 ANGSTROMS FOR ALL ATOMS. THE AVERAGE STRUCTURE WAS THEN CALCULATED BY BEST FIT SUPERPOSITION, COORDINATE AVERAGING AND RESTRAINED ENERGY MINIMIZATION.
simulated annealing
BRUNGER
refinement
X-PLOR
3.84
structure solution
XPLOR
600
Varian
UNITYPLUS
n
1
0
A
GLU
1
n
2
GLU
1
A
ASP
2
n
3
ASP
2
A
LEU
3
n
4
LEU
3
A
PRO
4
n
5
PRO
4
A
HIS
5
n
6
HIS
5
A
HIS
6
n
7
HIS
6
A
ASP
7
n
8
ASP
7
A
GLU
8
n
9
GLU
8
A
LYS
9
n
10
LYS
9
A
THR
10
n
11
THR
10
A
TRP
11
n
12
TRP
11
A
ASN
12
n
13
ASN
12
A
VAL
13
n
14
VAL
13
A
GLY
14
n
15
GLY
14
A
SER
15
n
16
SER
15
A
SER
16
n
17
SER
16
A
ASN
17
n
18
ASN
17
A
ARG
18
n
19
ARG
18
A
ASN
19
n
20
ASN
19
A
LYS
20
n
21
LYS
20
A
ALA
21
n
22
ALA
21
A
GLU
22
n
23
GLU
22
A
ASN
23
n
24
ASN
23
A
LEU
24
n
25
LEU
24
A
LEU
25
n
26
LEU
25
A
ARG
26
n
27
ARG
26
A
GLY
27
n
28
GLY
27
A
LYS
28
n
29
LYS
28
A
ARG
29
n
30
ARG
29
A
ASP
30
n
31
ASP
30
A
GLY
31
n
32
GLY
31
A
THR
32
n
33
THR
32
A
PHE
33
n
34
PHE
33
A
LEU
34
n
35
LEU
34
A
VAL
35
n
36
VAL
35
A
ARG
36
n
37
ARG
36
A
GLU
37
n
38
GLU
37
A
SER
38
n
39
SER
38
A
SER
39
n
40
SER
39
A
LYS
40
n
41
LYS
40
A
GLN
41
n
42
GLN
41
A
GLY
42
n
43
GLY
42
A
CYS
43
n
44
CYS
43
A
TYR
44
n
45
TYR
44
A
ALA
45
n
46
ALA
45
A
CYS
46
n
47
CYS
46
A
SER
47
n
48
SER
47
A
VAL
48
n
49
VAL
48
A
VAL
49
n
50
VAL
49
A
VAL
50
n
51
VAL
50
A
ASP
51
n
52
ASP
51
A
GLY
52
n
53
GLY
52
A
GLU
53
n
54
GLU
53
A
VAL
54
n
55
VAL
54
A
LYS
55
n
56
LYS
55
A
HIS
56
n
57
HIS
56
A
CYS
57
n
58
CYS
57
A
VAL
58
n
59
VAL
58
A
ILE
59
n
60
ILE
59
A
ASN
60
n
61
ASN
60
A
LYS
61
n
62
LYS
61
A
THR
62
n
63
THR
62
A
ALA
63
n
64
ALA
63
A
THR
64
n
65
THR
64
A
GLY
65
n
66
GLY
65
A
TYR
66
n
67
TYR
66
A
GLY
67
n
68
GLY
67
A
PHE
68
n
69
PHE
68
A
ALA
69
n
70
ALA
69
A
GLU
70
n
71
GLU
70
A
PRO
71
n
72
PRO
71
A
TYR
72
n
73
TYR
72
A
ASN
73
n
74
ASN
73
A
LEU
74
n
75
LEU
74
A
TYR
75
n
76
TYR
75
A
SER
76
n
77
SER
76
A
SER
77
n
78
SER
77
A
LEU
78
n
79
LEU
78
A
LYS
79
n
80
LYS
79
A
GLU
80
n
81
GLU
80
A
LEU
81
n
82
LEU
81
A
VAL
82
n
83
VAL
82
A
LEU
83
n
84
LEU
83
A
HIS
84
n
85
HIS
84
A
TYR
85
n
86
TYR
85
A
GLN
86
n
87
GLN
86
A
HIS
87
n
88
HIS
87
A
THR
88
n
89
THR
88
A
SER
89
n
90
SER
89
A
LEU
90
n
91
LEU
90
A
VAL
91
n
92
VAL
91
A
GLN
92
n
93
GLN
92
A
HIS
93
n
94
HIS
93
A
ASN
94
n
95
ASN
94
A
ASP
95
n
96
ASP
95
A
SER
96
n
97
SER
96
A
LEU
97
n
98
LEU
97
A
ASN
98
n
99
ASN
98
A
VAL
99
n
100
VAL
99
A
THR
100
n
101
THR
100
A
LEU
101
n
102
LEU
101
A
ALA
102
n
103
ALA
102
A
TYR
103
n
104
TYR
103
A
PRO
104
n
105
PRO
104
A
VAL
105
n
106
VAL
105
A
TYR
106
n
107
TYR
106
A
ALA
107
n
108
ALA
107
A
GLN
108
n
109
GLN
108
A
GLN
109
n
110
GLN
109
A
ARG
110
n
111
ARG
110
A
ARG
111
n
112
ARG
111
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LEU
34
A
O
LEU
35
A
N
SER
47
A
N
SER
48
A
O
TYR
44
A
O
TYR
45
A
N
ILE
59
A
N
ILE
60
1
A
MET
0
A
MET
1
1
Y
1
A
A
O
H
GLU
ASN
8
12
1.39
1
A
A
HE
O
ARG
GLU
36
37
1.40
1
A
A
O
H
TRP
VAL
11
35
1.56
1
A
A
O
H
TYR
ILE
44
59
1.58
1
A
SER
15
-92.54
44.74
1
A
SER
39
118.15
-103.62
1
A
ASP
51
-49.85
-10.96
1
A
TYR
66
64.25
-17.23
1
A
VAL
91
-23.93
-43.87
1
A
GLN
92
-55.35
175.27
1
A
ASN
94
119.67
-12.53
1
A
ASP
95
58.42
11.40
model building
X-PLOR
3.84
refinement
X-PLOR
3.84
phasing
X-PLOR
3.84
SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE, NMR, MINIMIZED AVERAGE STRUCTURE
1
Y
N
A
PRO
4
A
PRO
5
HELX_P
A
HIS
6
A
HIS
7
5
1
3
A
GLU
8
A
GLU
9
HELX_P
A
TRP
11
A
TRP
12
1
2
4
A
ARG
18
A
ARG
19
HELX_P
A
LEU
25
A
LEU
26
1
3
8
A
LEU
78
A
LEU
79
HELX_P
A
HIS
87
A
HIS
88
1
4
10
SH2 DOMAIN
SH2 DOMAIN, P85ALPHA, PI 3-KINASE, C TERMINAL SH2 DOMAIN
P85A_BOVIN
UNP
1
1
P23727
MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEAKPEEIGWLNGYNETTGERGDFPGTYVEYIGRK
KISPPTPKPRPPRPLPVAPGPSKTEADSEQQASTLPDLAEQFAPPDVAPPLLIKLVEAIEKKGLECSTLYRTQSSSNPAE
LRQLLDCDTASLDLEMFDVHVLADAFKRYLLDLPNPVIPVAVSSELISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTL
QYLLKHFFKLSQTSSKNLLNARVLSELFSPLLFRFPAASSENTEHLIKIIEILISTEWNERQPAPALPPKPPKPTTVANN
GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFNS
VVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEDYTRTSQEIQMK
RTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNETEIQRIMHNYEKLKSRISEIVDSRRRLEEDLKKQAAEYREID
KRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRG
KRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYA
QQRR
614
724
1BFJ
1
111
P23727
A
1
2
112
3
anti-parallel
anti-parallel
A
PHE
33
A
PHE
34
A
GLU
37
A
GLU
38
A
TYR
44
A
TYR
45
A
VAL
49
A
VAL
50
A
VAL
54
A
VAL
55
A
ILE
59
A
ILE
60
1
P 1